-
September 10: The Week in Cancer News
9/11 first responders' cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers
by Marci A. Landsmann
-
An Emerging Treatment for Metastatic Prostate Cancer
A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
August 27: The Week in Cancer News
Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.
by Bradley Jones
-
August 20: The Week in Cancer News
Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.
by Marci A. Landsmann
-
August 13: The Week in Cancer News
Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.
by Kevin McLaughlin
-
Drug Delays Recurrence in People With Early-Stage Breast Cancer
People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
-
July 30: The Week in Cancer News
Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.
by Marci A. Landsmann
-
July 23: The Week in Cancer News
Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.
by Kevin McLaughlin
-
Remote Care
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.
by Jon Kelvey
-
July 16: The Week in Cancer News
A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.
by Bradley Jones
Cancer Talk
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung Cancer
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
Self-collection Broadens Access to HPV ScreeningFDA approval allows patients to collect samples for HPV test, lowering a barrier to an important cancer prevention tool.
by Taneia Surles
To Understand Disparities, Look at the Broader ContextsResearchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.
by Eric Fitzsimmons
Cancer Care Does Not Move in Straight LinesCathy Nobil-Dutton did all the right things to protect her health, but a uterine cancer diagnosis showed her life doesn’t always go as expected.
by Cathy Nobil-Dutton